MedTech Dive March 25, 2025
Elise Reuter

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.

Dexcom is preparing to launch a 15-day version of its G7 continuous glucose monitor, based on data presented Thursday at the Advanced Technologies & Treatments for Diabetes conference.

Dexcom pointed to data claiming its updated CGM is the most accurate. The results show a mean absolute relative difference of 8% — a widely used measurement comparing CGM results to blood glucose readings. Dexcom has submitted an application for the 15-day sensor to the Food and Drug Administration for clearance.

Using technology to manage Type 2 diabetes was also a focus at the conference. Dexcom shared results of a survey...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Conferences / Podcast, Digital Health, Interview / Q&A, Technology, Trends, Wearables
Related Articles:
FDA guidance eases wearables oversight. But experts have questions about what’s next.
Dual-Sensor Smartwatch May Boost Detection of Silent AF
Two App Updates Make The Apple Watch Even Better For Fitness Tracking
The Smart Sleep Alarm Is The Holy Grail Of Health Tracking - 2
Sleep trackers are popular, but what do they really measure?

Share Article